02-05-2025
Goldman Sachs Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)
In a report released yesterday, David Roman from Goldman Sachs maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report), with a price target of $82.00. The company's shares closed yesterday at $67.67.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Roman covers the Healthcare sector, focusing on stocks such as Teladoc, LivaNova, and GE Healthcare Technologies Inc. According to TipRanks, Roman has an average return of 0.1% and a 54.05% success rate on recommended stocks.
Currently, the analyst consensus on GE Healthcare Technologies Inc is a Strong Buy with an average price target of $89.75, implying a 32.63% upside from current levels. In a report released on April 30, BTIG also reiterated a Buy rating on the stock with a $82.00 price target.
Based on GE Healthcare Technologies Inc's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.78 billion and a net profit of $564 million. In comparison, last year the company earned a revenue of $4.65 billion and had a net profit of $374 million
Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GEHC in relation to earlier this year. Most recently, in February 2025, George A. Newcomb, the CAO of GEHC sold 2,000.00 shares for a total of $185,080.00.
